Tirzepatide improves health-related quality of life vs insulin lispro in poorly controlled basal insulin-treated adults with type 2 diabetes (SURPASS-6)

被引：0
|
作者：
Boye, K. [1 ]
Sapin, H. [1 ]
Poon, J. -L. [1 ]
Lando, L. Fernandez [1 ]
Huh, R. [1 ]
Wang, M. [2 ]
Patel, H. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN USA
[2] Syneos Hlth, Morrisville, NC USA
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
624
引用
收藏
页码：S314 / S314
页数：1
相关论文
共 50 条
  • [1] Tirzepatide Improves HRQoL Compared with Insulin Lispro in Poorly Controlled Basal Insulin-Treated Adults with Long-Standing T2D (SURPASS-6)
    Boye, Kristina
    Sapin, Helene
    Poon, Jiat Ling
    Lando, Laura Fernandez
    Huh, Ruth
    Wang, Mianbo
    Patel, Hiren
    DIABETES, 2023, 72
  • [2] Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6)
    Boye, Kristina Secnik
    Poon, Jiat Ling
    Lando, Laura Fernandez
    Sapin, Helene
    Huh, Ruth
    Wang, Mianbo
    Williamson, Suzanne
    Patel, Hiren
    DIABETES THERAPY, 2024, 15 (09) : 2039 - 2059
  • [3] Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes The SURPASS-6 Randomized Clinical Trial
    Rosenstock, Julio
    Frias, Juan P.
    Rodbard, Helena W.
    Tofe, Santiago
    Sears, Emmalee
    Huh, Ruth
    Lando, Laura Fernandez
    Patel, Hiren
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (17): : 1631 - 1640
  • [4] "Surpass(ing)" an era of basal-bolus insulin therapy: tirzepatide vs insulin lispro tid added-on to poorly controlled basal insulin-treated type 2 diabetes
    Frias, J. P.
    Rosenstock, J.
    Rodbard, H. W.
    Tofe, S.
    Sears, E.
    Huh, R.
    Lando, L. Fernandez
    Patel, H.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S5 - S6
  • [5] Tirzepatide versus insulin lispro in type 2 diabetes: SURPASS-6 trial
    Clauss, R. Maria
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (01) : 26 - 26
  • [6] "SURPASS(ing)" an Era of Basal-Bolus Insulin Therapy-Tirzepatide vs. Insulin Lispro TID Added-on to Poorly Controlled Basal Insulin-Treated in Type 2 Diabetes
    Rosenstock, Julio
    Frias, Juan P.
    Rodbard, Helena W.
    Tofe, Santiago
    Sears, Emmalee J.
    Huh, Ruth
    Lando, Laura Fernandez
    Patel, Hiren
    DIABETES, 2023, 72
  • [7] Tirzepatide vs insulin lispro added to basal insulin in type 2 diabetes: the SURPASS-6 randomized clinical trial ( vol 330, pg 1631, 2023)
    Rosentock, J.
    Frias, J. P.
    Rodbard, H. W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,
  • [8] Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial (oct , 10.1001/jama.2023.20294 , 2023)
    Rosentock, J.
    Frias, J. P.
    Rodbard, H. W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (19): : 1915 - 1915
  • [9] A comparison of health-related quality of life of elderly and younger insulin-treated adults with diabetes
    Trief, PM
    Wade, MJ
    Pine, D
    Weinstock, RS
    AGE AND AGEING, 2003, 32 (06) : 613 - 618
  • [10] Health-related quality of life and health utilities in insulin-treated type 2 diabetes: the impact of related comorbidities/complications
    John Yfantopoulos
    Athanasios Chantzaras
    The European Journal of Health Economics, 2020, 21 : 729 - 743
12345